Cargando…
Aberrant WNT/β-catenin signaling in parathyroid carcinoma
BACKGROUND: Parathyroid carcinoma (PC) is a very rare malignancy with a high tendency to recur locally, and recurrent disease is difficult to eradicate. In most western European countries and United States, these malignant neoplasms cause less than 1% of the cases with primary hyperparathyroidism, w...
Autores principales: | Svedlund, Jessica, Aurén, Maria, Sundström, Magnus, Dralle, Henning, Åkerström, Göran, Björklund, Peyman, Westin, Gunnar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993678/ https://www.ncbi.nlm.nih.gov/pubmed/21078161 http://dx.doi.org/10.1186/1476-4598-9-294 |
Ejemplares similares
-
An LRP5 Receptor with Internal Deletion in Hyperparathyroid Tumors with Implications for Deregulated WNT/β-Catenin Signaling
por: Björklund, Peyman, et al.
Publicado: (2007) -
Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients
por: Björklund, Peyman, et al.
Publicado: (2008) -
The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer
por: Björklund, Peyman, et al.
Publicado: (2009) -
Aberrant Activation of the WNT/β-Catenin Signaling Pathway in Lupus Nephritis
por: Wang, Xiao-dong, et al.
Publicado: (2014) -
Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells
por: Chen, Changbao, et al.
Publicado: (2015)